Strategic effects of corporate venture capital investments

Anokhin, 2006 Anokhin, 2011, Operationalizing opportunities in entrepreneurship research: use of data envelopment analysis, Small Bus. Econ., 37, 39, 10.1007/s11187-009-9227-1 Benson, 2009, Corporate venture capital as a window on new technologies: Implications for the performance of corporate investors when acquiring startups, Organ. Sci., 20, 329, 10.1287/orsc.1080.0386 Bourgeois, 1981, On the measurement of organizational slack, Acad. Manag. Rev., 6, 29, 10.5465/amr.1981.4287985 Chesbrough, 2002, Making sense of corporate venture capital, Harv. Bus. Rev., 80, 4 Cockburn, 2000, Untangling the origins of competitive advantage, Strat. Manag. J., 21, 1123, 10.1002/1097-0266(200010/11)21:10/11<1123::AID-SMJ130>3.0.CO;2-R Coelli, T.J., 1996. A Guide to FRONTIER version 4.1: a Computer Program for Stochastic Frontier Production and Cost Function Estimation. CEPA Working Paper, Vol. 96, No. 07, pp. 1–32 Collinson, 2001, Knowledge management capabilities in R&D: A U.K.-Japan company comparison, R&D Manag., 31, 335, 10.1111/1467-9310.00221 Cox, 2013 Durand, 2003, Ownership, organization, and private firms' efficient use of resources, Strat. Manag. J., 24, 667, 10.1002/smj.321 Dushnitsky, 2004, Limitations to inter-organizational knowledge acquisition: The paradox of corporate venture capital, Acad. Manag. Proc., C1, 10.5465/AMBPP.2004.13857487 Dushnitsky, 2005, When do incumbents learn from entrepreneurial ventures? Corporate venture capital and investing firm innovation rates, Res. Policy, 34, 615, 10.1016/j.respol.2005.01.017 Ernst and Young. 2002. Corporate Venture Capital Report. 〈http://www.ey.com/global/download.nsf/International/Ernst_&_Young_-_Global_Venture_Capital_Report_2002/$file/2002_CVC_Report.pdf〉. Fare, 1994, Productivity growth, technical progress, and efficiency change in industrialized countries, Am. Econ. Rev., 84, 66 Gompers, P.A., Lerner, J. 1998. The determinants of corporate venture capital success: organizational structure, incentives, and complementarities. NBER Working Paper # 6725. Henderson, 1994, The evolution of integrative capability: Innovation in cardiovascular drug discovery, Ind. Corp. Chang., 3, 607, 10.1093/icc/3.3.607 Hollingsworth, 2004, Non parametric efficiency measurement, Econ. J., 114, F307, 10.1111/j.1468-0297.2004.00224.x Malmquist, 1953, Index numbers and indifference surfaces, Trab. Estat., 4, 209, 10.1007/BF03006863 Penrose, 1959 Reaume, 2003, Is Corporate Venture Capital a Prescription for Success in the Pharmaceutical Industry?, J. Priv. Equity, 77, 10.3905/jpe.2003.320058 Riyanto, Y.E., Schwienbacher, A., 2005. The Strategic use of Corporate Venture Financing for Securing Demand. Working Paper. Schilling, 2002, Technology success and failure in winner-take-all markets: The Impact of learning orientation, timing, and network externalities, Acad. Manag. J., 45, 387, 10.2307/3069353 Singh, 1986, Performance, slack, and risk taking in organizational decision making, Acad. Manag. J., 29, 562, 10.2307/256224 Thursby, 2002, Who is selling the ivory tower? Sources of growth in university licensing, Manag. Sci., 48, 90, 10.1287/mnsc.48.1.90.14271 Yeoh, 1999, An empirical analysis of sustained advantage in the U.S. pharmaceutical industry: impact of firm resources and capabilities, Strat. Manag. J., 20, 637, 10.1002/(SICI)1097-0266(199907)20:7<637::AID-SMJ42>3.0.CO;2-Z Zajac, 1991, New organizational forms for enhancing innovation: The case of internal corporate joint ventures, Manag. Sci., 37, 170, 10.1287/mnsc.37.2.170